Evolent Health: Let The Bidding Begin
Evolent Health is potentially being taken private at a bid of $3.8 billion, offering a 15% upside to the stock at $32 per share. The company's revenue growth rates are expected to decelerate, but potential bidding wars may drive up the stock price further. Evolent's current valuation at 21x forward free cash flow may undervalue the company, potentially leading to higher bids in the future.
Exclusive: Evolent Health in sale talks after inbound interest, sources say
Evolent Health is in talks with private equity firms and other companies for a potential sale, in a process that kicked off after the healthcare services provider received inbound interest, people familiar with the matter said on Thursday.
Evolent Health (EVH) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript
Evolent Health, Inc. (EVH) Q2 2024 Earnings Call Transcript
Evolent Health (EVH) Surpasses Q2 Earnings and Revenue Estimates
Evolent Health (EVH) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.14 per share a year ago.
Evolent Health (EVH) Moves 12.8% Higher: Will This Strength Last?
Evolent Health (EVH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
